When should a biliary (bile duct) stent be removed after extraction of common bile duct stones in a patient with a history of recurrent stone formation or altered biliary anatomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Biliary Stent Removal After Common Bile Duct Stone Extraction

Biliary stents placed after common bile duct stone extraction should be removed within 1-2 weeks, with definitive duct clearance or further intervention planned within 4-6 weeks maximum. 1, 2

Primary Recommendation: Short-Term Stenting Only

The short-term use of a biliary stent followed by further endoscopy or surgery is strongly recommended to ensure adequate biliary drainage. 3 Stenting is intended as a temporary bridge to definitive treatment, not as sole therapy. 3

Critical Timing Considerations

  • Remove stents at 1-2 weeks following insertion, as longer periods significantly increase the risk of complications including cholangitis, stent occlusion, and stone formation around the stent. 1
  • Complete definitive treatment within 4-6 weeks of initial stent placement to minimize complications. 2, 4
  • Plastic stents have limited patency of approximately 3 months before occlusion becomes likely, making early removal essential. 5

When Stenting is Appropriate

Biliary stenting after stone extraction is indicated in specific scenarios:

  • Incomplete stone extraction at initial ERCP requiring staged procedures. 3
  • Severe acute cholangitis requiring immediate drainage before definitive stone removal. 3
  • Large or impacted stones (>10-15 mm) where lithotripsy or additional techniques will be needed. 3, 6
  • Temporary bridge while awaiting surgery or repeat ERCP. 7, 8

Definitive Management Algorithm

For Patients with Gallbladder In Situ

  1. Remove stent at 1-2 weeks and confirm complete duct clearance. 1
  2. Perform cholecystectomy within 2-4 weeks after successful bile duct clearance. 2, 4
  3. This approach reduces mortality from 14.1% to 7.9% (RR 1.78,95% CI 1.15-2.75) and significantly decreases recurrent biliary events. 1, 2

For High-Risk Surgical Patients

  • Biliary sphincterotomy with complete endoscopic duct clearance is an acceptable alternative to cholecystectomy. 3
  • Stenting as sole definitive treatment should be restricted only to patients with limited life expectancy or prohibitive surgical risk. 3, 2
  • Even in elderly patients (mean age 76 years), long-term stenting carries a 13% risk of cholangitis requiring intervention. 7, 8

Common Pitfalls and How to Avoid Them

Leaving Stents Too Long

  • Stents left beyond 2 months are associated with complications including cholangitis (13%), stone formation around the stent, and stent migration. 5, 7, 6
  • A case report documented a 2cm stone developing around a stent left for 2 years, highlighting the critical importance of timely removal. 5

Using Stenting as Definitive Treatment Inappropriately

  • Clearance of bile duct stones is the standard of care, not long-term stenting. 3, 2
  • Patients should be referred to specialist centers for advanced endoscopic therapy or surgery if standard techniques fail. 3
  • Long-term stenting without definitive treatment results in recurrent cholangitis in up to 13% of cases despite stent presence. 7, 8

Inadequate Follow-Up Planning

  • At stent placement, schedule the removal procedure within 1-2 weeks and definitive treatment within 4-6 weeks. 1, 2
  • Temporary stenting with a single 7F double pigtail stent is effective for drainage, but requires adherence to protocol with planned stent exchange every 3 months if longer duration is unavoidable. 9, 8
  • Non-adherence to scheduled stent exchange protocols results in complications in 70% of cases. 9

Special Populations

Recurrent Stone Formation

  • For patients with history of recurrent stones, complete duct clearance with cholecystectomy is mandatory rather than long-term stenting. 2
  • Recurrent common bile duct stones occur in 15-23.7% of patients with residual gallbladder stones versus only 5.9-11.3% with empty gallbladder. 3

Altered Biliary Anatomy

  • In Roux-en-Y or other altered anatomy, percutaneous or EUS-guided approaches may be needed for stent removal and stone clearance. 3
  • Conventional ERCP has only 33% success rate in Roux-en-Y anatomy, necessitating alternative techniques. 3

Evidence for Staged Approach with Temporary Stenting

Research demonstrates that stent placement for approximately 2 months can facilitate stone clearance by allowing large stones to become smaller and small stones to disappear, with 93% clearance rate at second ERCP. 6 However, this benefit must be weighed against complication risks, making the 1-2 week removal timeline with planned repeat intervention the safest approach. 1

References

Guideline

Management of Cholecystitis with Biliary Stent

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Common Hepatic Duct Stones After Unsuccessful ERCP

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Pancreatic Duct and Bile Duct Enlargement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Removal of a large stone growing around and encasing a plastic biliary stent: respect the ductal axis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009

Research

Clinical experience with endoscopic stents for treatment of common bile duct stones.

Journal of the Formosan Medical Association = Taiwan yi zhi, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.